Products for Research Use Only
RegisterLogin

CID5721353

CAT: 0013-GTR19162682-01Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19162682-01Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
BCL6 inhibitor 79-6 (Compound 79-6) is the first-generation, specific BCL6 BTB domain inhibitor with IC50 of 200 uM, Kd of 129 uM; binds to a pocket in the lateral groove of the BCL6 BTB domain, specifically inhibits BCL6 but not other BTB-ZF proteins; disrupts BCL6/corepressor complexes and reactivates BCL6 target genes in vitro and in vivo, selectively kills BCL6-dependent DLBCL cells; suppresses human DLBCL xenografts in mice with favorable pharmacokinetics.
CAS Number
301356-95-6
Product Name Alternative
CID5721353 | CID-5721353 | CID 5721353 | BCL6 Inhibitor
Purity
>98% (HPLC)
Solubility
< 1 mg/ml refers to the product slightly soluble or insoluble
Smiles
O=C (O) C (N (C/1=O) C (SC1=C2C (NC3=C/2C=C (Br) C=C3) =O) =S) CC (O) =O
Molecular Formula
C15H9BrN2O6S2
Molecular Weight
457.269
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(Z) -2- (5- (5-bromo-2-oxoindolin-3-ylidene) -4-oxo-2-thioxothiazolidin-3-yl) succinic acid

Alternative Products

CatalogName
BMA35695-01CID5721353
A16192-50CID5721353 50mg
A16192-5CID5721353 5mg
A16192-25CID5721353 25mg
A16192-10CID5721353 10mg
A16192-200CID5721353 200mg
A16192-100CID5721353 100mg
A16192-2CID5721353 2mg
HY-100502RCID5721353 (Standard)
S8250-25mg79-6 (CID5721353)

Popular Products